» Articles » PMID: 28271447

Guards at the Gate: Physiological and Pathological Roles of Tissue-resident Innate Lymphoid Cells in the Lung

Overview
Journal Protein Cell
Date 2017 Mar 9
PMID 28271447
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The lung is an important open organ and the primary site of respiration. Many life-threatening diseases develop in the lung, e.g., pneumonia, asthma, chronic obstructive pulmonary diseases (COPDs), pulmonary fibrosis, and lung cancer. In the lung, innate immunity serves as the frontline in both anti-irritant response and anti-tumor defense and is also critical for mucosal homeostasis; thus, it plays an important role in containing these pulmonary diseases. Innate lymphoid cells (ILCs), characterized by their strict tissue residence and distinct function in the mucosa, are attracting increased attention in innate immunity. Upon sensing the danger signals from damaged epithelium, ILCs activate, proliferate, and release numerous cytokines with specific local functions; they also participate in mucosal immune-surveillance, immune-regulation, and homeostasis. However, when their functions become uncontrolled, ILCs can enhance pathological states and induce diseases. In this review, we discuss the physiological and pathological functions of ILC subsets 1 to 3 in the lung, and how the pathogenic environment affects the function and plasticity of ILCs.

Citing Articles

Prediction of mortality risk in patients with severe community-acquired pneumonia in the intensive care unit using machine learning.

Pan J, Guo T, Kong H, Bu W, Shao M, Geng Z Sci Rep. 2025; 15(1):1566.

PMID: 39794470 PMC: 11723911. DOI: 10.1038/s41598-025-85951-x.


Lung Immune Cell Niches and the Discovery of New Cell Subtypes.

Shan Q, Qiu J, Dong Z, Xu X, Zhang S, Ma J Adv Sci (Weinh). 2024; 11(45):e2405490.

PMID: 39401416 PMC: 11615829. DOI: 10.1002/advs.202405490.


The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice.

Bahhar I, Es Z, Kose O, Turna A, Gunluoglu M, Cakir A Front Immunol. 2023; 14:1244437.

PMID: 37781372 PMC: 10540623. DOI: 10.3389/fimmu.2023.1244437.


RNA Modification in Inflammatory Bowel Diseases.

Nakayama M, Ozato Y, Tsuji Y, Arao Y, Otsuka C, Hamano Y Biomedicines. 2022; 10(7).

PMID: 35885000 PMC: 9313455. DOI: 10.3390/biomedicines10071695.


Respiratory Influenza Virus Infection Causes Dynamic Tuft Cell and Innate Lymphoid Cell Changes in the Small Intestine.

Roach S, Fiege J, Shepherd F, Wiggen T, Hunter R, Langlois R J Virol. 2022; 96(9):e0035222.

PMID: 35446142 PMC: 9093116. DOI: 10.1128/jvi.00352-22.


References
1.
Halim T, Hwang Y, Scanlon S, Zaghouani H, Garbi N, Fallon P . Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses. Nat Immunol. 2015; 17(1):57-64. PMC: 4685755. DOI: 10.1038/ni.3294. View

2.
Vosshenrich C, Ranson T, Samson S, Corcuff E, Colucci F, Rosmaraki E . Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol. 2005; 174(3):1213-21. DOI: 10.4049/jimmunol.174.3.1213. View

3.
Taube C, Tertilt C, Gyulveszi G, Dehzad N, Kreymborg K, Schneeweiss K . IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS One. 2011; 6(7):e21799. PMC: 3138740. DOI: 10.1371/journal.pone.0021799. View

4.
Yasuda K, Muto T, Kawagoe T, Matsumoto M, Sasaki Y, Matsushita K . Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci U S A. 2012; 109(9):3451-6. PMC: 3295287. DOI: 10.1073/pnas.1201042109. View

5.
Liu J, Wu J, Qi F, Zeng S, Xu L, Hu H . Natural helper cells contribute to pulmonary eosinophilia by producing IL-13 via IL-33/ST2 pathway in a murine model of respiratory syncytial virus infection. Int Immunopharmacol. 2015; 28(1):337-43. DOI: 10.1016/j.intimp.2015.05.035. View